#LCSM Chat Topic 9/3/2020: Is #Cancer Advocacy for Everyone?

The September 3 #LCSM Chat will tackle the issue of making time for cancer advocacy. Most media outlets shared that “Black Panther” star Chadwick Boseman died of colon cancer last week at age 43. He kept his illness a secret, and managed to complete several major film projects while dealing with surgeries and chemotherapy sessions.  While such a high-profile entertainer might have made a powerful colon cancer advocate, his choice to keep working as an actor has had (and continues to have) a positive impact on millions of lives internationally. It’s hard… Read More

#LCSM Chat Topic 4/2/2020: #COVID19 and #LungCancer

It seems that the world has turned upside down.  At the time I write this, there have been almost 550,00 cases of COVID-19 confirmed in the world and over 85,000 in the US.  Here in New York City there have been over 23,000 cases and 365 deaths as of March 27th (https://coronavirus.jhu.edu/map.html). The pandemic has placed enormous stress on our health care delivery system.  For lung cancer patients, it has affected healthcare providers’ ability to perform tests and radiologic procedures; provide timely diagnosis, staging, and care for early stage patients; and, in… Read More

#LCSM Chat Topic 3/5/2020: Expanding Access to Cancer Clinical Trials

Cancer research is necessary if we are to find more durable treatments for all cancers. While research has come a long way, we still have a long way to go in order to establish quality, durable treatments for many diagnosed with advanced/metastatic disease.  Typically research begins, “at the bench” with cell lines and in organoids. Once an idea has shown some promise, it often moves on to testing in animals. When an idea, test or therapeutic shows significant promise, it must move to clinical trials. Clinical trials, allow diagnostic tests, screening methods,… Read More